Growth Metrics

Quantum Biopharma (QNTM) Non Operating Income (2022 - 2024)

Quantum Biopharma recorded quarterly Non Operating Income of -$10371.0 in Q3 2024, down 2829.21% quarter-over-quarter from $380.0 in Q3 2023, and down 2829.21% year-over-year from $380.0 in Q4 2023.

Quantum Biopharma's Non Operating Income history runs 3 years deep, the most recent figure standing at -$10371.0 for Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 444,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 201.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -46.98 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn - -8.59 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2024 -10,371.00
Sep 30, 2023 380.00
Sep 30, 2022 16,052.00